Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Food Effect, Pharmacokinetics, and Pharmacodynamics of JNJ-41443532 in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 04 Jun 2014
At a glance
- Drugs JNJ 41443532 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 19 Mar 2012 Actual initiation date changed from Mar 2010 to Feb 2010 as reported by ClinicalTrials.gov.
- 09 Sep 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 09 Sep 2010 Status change from recruiting to completed as reported by ClinicalTrials.gov.